Register for streaming realtime charts, analysis tools, and prices.
Period:
Draw Mode:
| Volume | 4,888 |
|
|||||
| News | - | ||||||
| Day High | 5.816 | Low High |
|||||
| Day Low | 5.62 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| electroCore Inc | ECOR | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.08 | -1.41% | 5.58 | 16:30:00 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 5.62 | 5.62 | 5.816 | 5.58 | 5.66 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 104 | 4,888 | $ 5.77 | $ 28,206 | - | 3.8285 - 8.08 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:00:00 | 203 | $ 5.58 | USD |
electroCore Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 34.52M | 6.00M | - | 16.03M | -18.83M | -3.14 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
electroCore News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ECOR Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 5.58 | 6.3399 | 5.32 | 5.62 | 8,208 | 0.00 | 0.00% |
| 1 Month | 6.15 | 6.77 | 5.32 | 5.90 | 10,463 | -0.57 | -9.27% |
| 3 Months | 7.73 | 7.80 | 5.32 | 6.49 | 9,879 | -2.15 | -27.81% |
| 6 Months | 5.34 | 8.08 | 5.02 | 6.26 | 13,073 | 0.24 | 4.49% |
| 1 Year | 6.73 | 8.08 | 3.8285 | 5.53 | 17,508 | -1.15 | -17.09% |
| 3 Years | 27.00 | 29.5485 | 2.925 | 13.60 | 630,211 | -21.42 | -79.33% |
| 5 Years | 92.70 | 96.675 | 2.925 | 23.71 | 1,171,444 | -87.12 | -93.98% |
electroCore Description
| electroCore Inc is a commercial stage bioelectronic medicine company with a platform for non-invasive vagus nerve stimulation therapy initially focused on neurology. The company's product gammaCore is Food and Drug Administration cleared in the United States for adjunctive use for the preventive treatment of cluster headache in adult patients, the acute treatment of pain associated with episodic cluster headache in adult patients, the acute treatment of pain associated with migraine headache in adult patients and the prevention of migraine in adult patients. The gammaCore is CE-marked in the European Union for the acute and/or prophylactic treatment of primary headache, Bronchoconstriction and Medication Overuse Headache in adults. |
